These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3079070)

  • 1. The value of hormonal therapy in improving organ viability in the transplant donor.
    Novitzky D; Cooper DK; Reichart B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2037-8. PubMed ID: 3079070
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of hormonal therapy in human brain-dead potential organ donors.
    Novitzky D; Cooper DK
    Transplant Proc; 1988 Oct; 20(5 Suppl 7):59-62. PubMed ID: 3055561
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormonal therapy in the brain-dead experimental animal.
    Cooper DK; Novitzky D; Wicomb WN
    Transplant Proc; 1988 Oct; 20(5 Suppl 7):51-4. PubMed ID: 3055559
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hormonal therapy on subsequent organ (kidney) storage in the experimental animal.
    Wicomb WN; Novitzky D; Cooper DK
    Transplant Proc; 1988 Oct; 20(5 Suppl 7):55-8. PubMed ID: 3055560
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors.
    Novitzky D; Cooper DK; Reichart B
    Transplantation; 1987 Jun; 43(6):852-4. PubMed ID: 3296351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triiodothyronine therapy for heart donor and recipient.
    Novitzky D; Cooper DK; Human PA; Reichart B; Zuhdi N
    J Heart Transplant; 1988; 7(5):370-6. PubMed ID: 3058907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional management of the brain-dead potential multi-organ donor.
    Turcotte JG
    Transplant Proc; 1988 Oct; 20(5 Suppl 7):5-8. PubMed ID: 2903591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Organ donation from a brain-dead patient. Donor criteria, organ-preserving therapy and discussion with the relatives].
    Prien T; Mertes N; Buchholz B; Lawin P
    Dtsch Med Wochenschr; 1989 Jun; 114(25):998-1002. PubMed ID: 2661187
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool.
    Jeevanandam V; Todd B; Hellman S; Eldridge C; McClurken J; Addonizio VP
    Transplant Proc; 1993 Dec; 25(6):3305-6. PubMed ID: 8266553
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy.
    Jeevanandam V; Todd B; Regillo T; Hellman S; Eldridge C; McClurken J
    J Heart Lung Transplant; 1994; 13(4):681-7; discussion 685-7. PubMed ID: 7947885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and metabolic effects of substitutive triiodothyronine therapy in organ donors.
    García-Fages LC; Cabrer C; Valero R; Manyalich M
    Transplant Proc; 1993 Dec; 25(6):3038-9. PubMed ID: 8266444
    [No Abstract]   [Full Text] [Related]  

  • 12. Organ donors: heartbeating and non-heartbeating.
    Kootstra G; Kievit J; Nederstigt A
    World J Surg; 2002 Feb; 26(2):181-4. PubMed ID: 11865348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone levels, hemodynamics, and metabolism in brain dead organ donors.
    Mariot J; Sadoune LO; Jacob F; Dousset B; Perrier JF; Jacob C; Strub P; Voltz C
    Transplant Proc; 1995 Feb; 27(1):793-4. PubMed ID: 7879187
    [No Abstract]   [Full Text] [Related]  

  • 14. [Donor heart preservation].
    Hayashi Y; Iwasaki M
    Masui; 2008 Jan; 57(1):60-8. PubMed ID: 18214006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-heart-beating donor program contributes 40% of kidneys for transplantation.
    Daemen JH; de Wit RJ; Bronkhorst MW; Yin M; Heineman E; Kootstra G
    Transplant Proc; 1996 Feb; 28(1):105-6. PubMed ID: 8644133
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain death and donor heart dysfunction: implications in cardiac transplantation.
    Apostolakis E; Parissis H; Dougenis D
    J Card Surg; 2010; 25(1):98-106. PubMed ID: 19549049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The possibilities of biological preservation of a multiple organ donor].
    Barinov EF
    Grudn Khir; 1988; (5):38-44. PubMed ID: 3061880
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant.
    Abdelnour T; Rieke S
    J Heart Lung Transplant; 2009 May; 28(5):480-5. PubMed ID: 19416777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In-situ preservation of kidneys of 'non-heart-beating' donors: a possible way to offset the shortage of donor kidneys].
    Kootstra G; van Hooff JP
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2838-43. PubMed ID: 10065258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in hemodynamic performance and oxygen consumption during brain death in the pig.
    Mertes PM; Burtin P; Carteaux JP; Pinelli G; Jaboin Y; Burlet C; Boulange M; Villemot JP
    Transplant Proc; 1994 Feb; 26(1):229-30. PubMed ID: 8108951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.